Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Citi: MGM CHINA (02282.HK) Continues Strong Biz Trend; TP Added to $18, Rating Kept at Buy
Recommend 19 Positive 42 Negative 16 |
||||
|
||||
|
MGM CHINA (02282.HK) achieved a historical high EBITDA of $2.511 billion in 2Q25, with a market share of 16.6% and an EBITDA margin of 29%, both of which being in line with management guidance, Citi Research issued a research report saying. The broker believed that this reflects its competitiveness and prudent spending, especially in player reinvestment, despite new offerings from SANDS CHINA LTD (01928.HK)'s Londoner Grand and GALAXY ENT (00027.HK)'s Capella. Business momentum remained strong in July 2025, with robust transaction volumes across all business segments, according to MGM CHINA's management. Given the recent solid trends, Citi Research expected MGM CHINA's newly opened suites and villas from July 2025 to mid-2026 to help maintain its market share. Therefore, the broker added its target price for MGM CHINA from $17.1 to $18, with rating kept at Buy. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
